Dan Stanton

WuXi Biologics’ share price spiked after the BIOSECURE Act failed to make the House Rules Committee’s list of floor amendments to the fiscal 2025 National Defense Authorization Act (NDAA).

Syncona has formed Spur Therapeutics after its recent gene therapy acquisition Freeline acquired inherited neurological disorder firm SwanBio.

Informa PLC | ABOUT US | INVESTOR RELATIONS | TALENT This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Novo Nordisk is in talks to acquire CDMO SK Pharmteco’ Petersburg, Virginia manufacturing facility for KRW 300 billion ($216 million), according to news reports.

The sale forms part of a strategy to reduce expenses says uniQure, adding Genezen will continue producing gene therapy Hemgenix for partner CSL from the Lexington, Massachusetts facility.

Avid Bioservices says it has doubled gross margin quarter-on-quarter due to capital expenditure projects – including a 53,000 square-foot viral vector plant – coming online.

The addition of Biovectra brings fill/finish services and two GMP plants in Canada to bioprocess tech firm Agilent’s CDMO offerings.

Amid the current mpox outbreak, Bavarian Nordic says it will have the capacity to manufacture 10 million doses of its vaccine by the end of 2025.

The proposed $925 million acquisition of Biovectra is only the start of Agilent’ ambition to lean into the CDMO space, the company says.

CDMO KBI Biopharma says a lack of capacity demand drove the U-turn on mammalian manufacturing, but the Geneva site will continue to offer other bioproduction services.